Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$549.31 USD

549.31
1,695,329

+24.03 (4.57%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $576.76 +27.45 (5.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (78 out of 251)

Industry: Medical - Dental Supplies

Zacks News

Stryker (SYK) to Report Q1 Earnings: What's in the Cards?

Stryker's (SYK) first-quarter results are expected to reflect strong segmental performances. However, rising costs are likely to have continued hurting margins.

DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?

DexCom's (DXCM) first-quarter results likely to reflect rising volumes across all channels.

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

What's in Store for West Pharmaceutical (WST) in Q1 Earnings?

West Pharmaceutical's (WST) first-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.

McKesson (MCK) Gains As Market Dips: What You Should Know

In the latest trading session, McKesson (MCK) closed at $359.27, marking a +1.05% move from the previous day.

Baxter (BAX) to Post Q1 Earnings: What's in the Offing?

Baxter's (BAX) first-quarter results are likely to reflect growth in elective surgical procedures, offset by currency movement. Hillrom's products might have boosted sales.

McKesson (MCK) Dips More Than Broader Markets: What You Should Know

McKesson (MCK) closed the most recent trading day at $362, moving -0.64% from the previous trading session.

Intuitive Surgical (ISRG) to Post Q1 Earnings: What's in Store?

Intuitive Surgical's (ISRG) first-quarter results likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs may have hurt margins.

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Here's Why You Should Retain McKesson (MCK) Stock for Now

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

Is SPDR Russell 1000 Low Volatility Focus ETF (ONEV) a Strong ETF Right Now?

Smart Beta ETF report for ONEV

McKesson (MCK) Stock Moves -0.21%: What You Should Know

McKesson (MCK) closed the most recent trading day at $362.99, moving -0.21% from the previous trading session.

McKesson (MCK) Gains As Market Dips: What You Should Know

McKesson (MCK) closed at $354.48 in the latest trading session, marking a +1.45% move from the prior day.

Is Henry Schein (HSIC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

McKesson (MCK) Stock Moves -1.63%: What You Should Know

In the latest trading session, McKesson (MCK) closed at $341.82, marking a -1.63% move from the previous day.

McKesson (MCK) Gains But Lags Market: What You Should Know

In the latest trading session, McKesson (MCK) closed at $339.92, marking a +1.36% move from the previous day.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

McKesson (MCK) Gains As Market Dips: What You Should Know

McKesson (MCK) closed the most recent trading day at $336.20, moving +0.07% from the previous trading session.

Here's Why You Should Retain McKesson (MCK) Stock Right Now

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

Nevro's (NVRO) Latest Launch to Customize Chronic Pain Treatment

Nevro's (NVRO) Senza HFX iQ SCS system is expected to treat individual patients per their particular treatment requirements.

Here's Why You Should Retain Catalent (CTLT) Stock for Now

Catalent's (CTLT) product and service launches and a slew of strategic deals raise optimism about the stock.

Cardinal Health's (CAH) New Tie-Up to Boost Patient Outcomes

Cardinal Health's (CAH) latest partnership is expected to improve patients' healthcare journey by offering a more integrated experience that connects all sites of care.

Three Reasons to Add BD (BDX) Stock to Your Portfolio Now

Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and product launches.

All You Need to Know About McKesson (MCK) Rating Upgrade to Buy

McKesson (MCK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).